U.S. markets open in 2 hours 50 minutes

Cellect Biotechnology Ltd. (APOP)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.5000-0.2900 (-10.39%)
At close: 4:00PM EDT

2.4500 -0.05 (-2.00%)
Pre-Market: 6:19AM EDT

Sign in to post a message.
  • J
    John
    Lots of news to come in next few weeks prior to QNRX listing in Nasdaq. Shorts will find it difficult to cover this give the short borrow rate and new merger details. Stay tuned, This is just my opinion. My 2 cents for what it is worth
  • y
    yonatan
    Just wait for the pop
    Bullish
  • K
    King
    100 million shares exchanged hands, while the float is not more than 4 million. Guess it has piled up huge shorts. if it is down, they make profit, if it is up, it shall create squeeze. I bet they will cover at the eod
  • P
    Pankaj
    I bought here and this will go back to 7 or higher tomorrow ......this is great entry
  • L
    Leo
    You have to read it not APOP but POPA ..........from right to left.
  • m
    matthew
    How else holding over night
    Bullish
  • H
    Haider
    Told ya!
    Bullish
  • C
    ChiliCheeseDog
    GOING TO 6+
    Bullish
  • F
    Flying Saucer
    Waiting for PR about apo graft phase 2 data.
    Neutral
  • N
    Nicole
    strategic merger with Quoin Pharmaceuticals.🚀🚀🚀
    Bullish
  • I
    Ingvard Arn
    fading sell means shorts got to cover and might make a big return
  • m
    matthew
    It will close red and open higher then today tomorrow morning
  • D
    Denis
    Will spike on opening
    Bullish
  • T
    Tom C
    This is soon 6 USD.
    Bullish
  • J
    J
    Wow did I over pay at 3.07? Lol
  • G
    GUNTER
    APOP is always good for a POP. I do not think somebody is pumping it but it is being played for sure. These day traders only make money if they run it up and down. I took the opportunity to unload some shares at $ 7.90. It went over $ 8.
  • K
    King
    tiny market cap bio tech stock, if up, could be to the moon. buy some around 5
  • N
    Nicole
    We look forward to accelerating the clinical development of our programs and delivering enhanced value to our shareholders,” stated Dr. Michael Myers, Chief Executive Officer of Quoin Pharmaceuticals.
  • O
    Olivier
    Like it or not this is the best looking stock pre market and they have a merger deal some volume. Should see a spike at market open, not expecting much but who knows these days.
  • E
    Eric S
    Up $1.50 AH and merger and no one talking!!